SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-13-000024
Filing Date
2013-05-08
Accepted
2013-05-08 16:33:48
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2013q110-q.htm 10-Q 1081144
2 EX-31.1 a2013q110-q_exhibit3111.htm EX-31.1 14536
3 EX-31.2 a2013q110-q_exhibit3121.htm EX-31.2 14370
4 EX-32.1 a2013q110-q_exhibit3211.htm EX-32.1 11756
  Complete submission text file 0000875320-13-000024.txt   7418239

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vrtx-20130331.xml EX-101.INS 1169918
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20130331.xsd EX-101.SCH 53972
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20130331_cal.xml EX-101.CAL 85021
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20130331_def.xml EX-101.DEF 182058
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20130331_lab.xml EX-101.LAB 622510
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20130331_pre.xml EX-101.PRE 322686
Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 13824988
SIC: 2834 Pharmaceutical Preparations